Prospective Minnesota Study of ECHO Tissue Doppler Imaging in Cardiac Resynchronization Therapy
Sponsor: Guidant Corporation
Listed as NCT00158015, this observational or N/A phase trial focuses on Heart Failure and remains completed. Sponsored by Guidant Corporation, it has been updated 9 times since 2004, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Apr 2020 — Jan 2021 [monthly]
Completed
▶ Show 4 earlier versions
-
May 2019 — Apr 2020 [monthly]
Completed
-
Jun 2018 — May 2019 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Oct 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Guidant Corporation
- Hennepin Healthcare Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .